Cargando…
Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer – the multinational MATEO study
BACKGROUND: The optimal duration of firstline chemotherapy in metastatic esophagogastric cancer is unknown. In most clinical trials therapy was given until tumour progression or limiting toxicity. Maintenance concepts aiming to prolong the duration of response and maintain quality of life have been...
Autores principales: | Haag, Georg-Martin, Stocker, Gertraud, Quidde, Julia, Jaeger, Dirk, Lordick, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537937/ https://www.ncbi.nlm.nih.gov/pubmed/28760152 http://dx.doi.org/10.1186/s12885-017-3497-9 |
Ejemplares similares
-
S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial
por: Stocker, G., et al.
Publicado: (2023) -
A phase II study for metabolic in vivo response monitoring with sequential (18)FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial
por: Berger, Anne Katrin, et al.
Publicado: (2012) -
Implementation of case management to reduce cardiovascular disease risk in the Stanford and San Mateo Heart to Heart randomized controlled trial: study protocol and baseline characteristics
por: Ma, Jun, et al.
Publicado: (2006) -
Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): The Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial
por: Lorenzen, Sylvie, et al.
Publicado: (2011) -
Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) – study protocol of a randomized controlled trial with gastrointestinal cancer patients
por: Quidde, Julia, et al.
Publicado: (2018)